Major players in biochips market include Agilent Technologies, Inc. (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
- Advertising -
Download Sample Brochure of Biochips Market spread across 170 pages, Profiling 12 Companies and supported with 76 Tables and 69 Figures is now available at www.rnrmarketresearch.com/contacts…mple?rname=540643 .
The biochips market is expected to reach USD 17.75 Billion by 2020 from USD 7.63 Billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are major drivers for biochips market.
However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent.
- Advertising -
2 Competitive Situation and Trends
3 Agreements, Partnerships, and Collaborations
5 Product Launches and Enhancements
7 Other Developments
Biochips market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. Based on applications, the DNA chips segment is categorized into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, agricultural biotechnology, drug discovery, and other applications (microbial genotyping, proteomics, toxicogenomics, screening and monitoring of patient data in clinical trials, and environmental biology).
More Information on Biochips Market with Company Profiles and Top Trends www.rnrmarketresearch.com/contacts/540643 .
The biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories).Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.
Key Target Audience:
- Biochip manufacturers and distributors
- Pharmaceutical companies
- Biotechnology companies
- Research institutes
- Academic Institutes
- Contract research organizations
- Research and consulting companies
In report, biochips market is segmented on basis of type, application, fabrication technology, end user, & region. Based on type, market is segmented into DNA chips, lab-on-a-chip, protein chips & other arrays.
Based on applications, lab-on-a-chip segment is classified into genomics, proteomics, drug discovery, IVD & POC clinical diagnostics, & other applications (biodefense, food pathogen identification, and environmental contamination).
Report at www.rnrmarketresearch.com/contacts/?rname=540643 .
This research report focuses on various levels of analysis - industry analysis (industry trends) and company profiles, which together comprise & discuss basic views on competitive landscape; emerging and high-growth segments of biochips market; high-growth regions; & market drivers, restraints, & opportunities.
Increasing adoption of personalized medicine, growing applications of biochips, & technological advancements are major drivers for biochips market. However, unclear regulatory guidelines, high instrumentation costs, & absolute quantification of specific mRNA may restrain market growth to a certain extent.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.